NAPEPLD

mutation — cross-omics
Cross-omicsMUTATION → RNACell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, NAPEPLD mutation is significantly associated with the RNA expression of many other genes, with 4 significant associations in total. BLOOD_Leukemia shows the largest number of these associations.

The most reproducible NAPEPLD-associated genes across cancer lineages are FATE1, PNLIPRP3, and CFHR2. Each is linked with NAPEPLD in more than 1 cancer types. Because this analysis shows association rather than direction, both NAPEPLD-to-partner and partner-to-NAPEPLD results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, FATE1 grouped by NAPEPLD-low versus NAPEPLD-high in BLOOD_Leukemia.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (NAPEPLD→partner) and Y-score (partner→NAPEPLD) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLOOD_LeukemiaFATE1 →+0.100+3.551<.001.00931
BLOOD_LeukemiaPNLIPRP3 →+0.008+3.551.007.00931
BLOOD_LeukemiaCFHR2 →+0.245+5.124<.001<.00131
LARGE_INTESTINESCRG1 →+0.024+3.793.002.00711
Each partner links to its Q-omics profile. Showing the 4 strongest of 4 associations by consensus.

FATE1 by NAPEPLD expression — BLOOD_Leukemia

Box plot of FATE1 in NAPEPLD-low vs NAPEPLD-high samples in BLOOD_Leukemia.

Explore this box plot interactively →

Exploration